Evidence map›Paper›PMID 42650685›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Mass Flux Analysis Reveals the Presence and Fate of Antimicrobials in Hospital Effluent, Wastewater Treatment Plant, and River Environments.

Takashi Azuma, Masaru Usui, Tomohiro Hasei, Tetsuya Hayashi

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takashi AzumaDepartment of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Japan.ORCID 0000-0002-9625-0631
Masaru UsuiFood Microbiology and Food Safety, Department of Health and Environmental Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan.ORCID 0000-0003-1624-1469
Tomohiro HaseiDepartment of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Japan.ORCID 0009-0000-9109-3617
Tetsuya HayashiDepartment of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Japan.

Funding

Japan Agency for Medical Research and Development JP22fk0108131Japan Agency for Medical Research and Development JP25fk0108666Ministry of Education, Culture, Sports, Science and Technology 20H02289Ministry of Education, Culture, Sports, Science and Technology 23H03553Ministry of Education, Culture, Sports, Science and Technology 24K15322Ministry of Health Labour and Welfare 21HA1002Ministry of Health Labour and Welfare 24HA1003Nippon Foundation of Japan- Osaka University Project for Infectious Disease Prevention
6 · The paper itself

Abstract

backgroundHospitals are recognized as important point sources of antimicrobials; however, their contributions to antimicrobial contamination at the watershed scale remain poorly understood.

methodsSeasonal monitoring was conducted between December 2024 and May 2026 at two hospitals, a wastewater treatment plant (WWTP), and receiving river waters in the Yodo River Basin, Japan. Seventeen antimicrobials were quantified, and concentration profiles and mass fluxes were integrated to evaluate source contributions.

resultsAmpicillin, levofloxacin, azithromycin, clarithromycin, and vancomycin were the predominant antimicrobials. Hospital wastewater was identified as the dominant source of ampicillin and vancomycin, whereas levofloxacin and clarithromycin were largely influenced by diffuse watershed inputs. Several antimicrobials persisted through wastewater treatment and were continuously detected in WWTP effluent and downstream river waters.

conclusionsThis watershed-scale assessment demonstrates that antimicrobial contamination is driven by both hospital-derived point sources and broader watershed inputs. These findings provide a scientific basis for integrated hospital wastewater and WWTP management to mitigate environmental antimicrobial resistance (AMR) within the One Health framework.

Indexed as

antimicrobial resistance (AMR)antimicrobialsenvironmental fatehospital wastewatermass fluxriver waterwastewater treatment plants (WWTPs)

Identifiers

PMID42650685
PMCPMC13509301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.